SCHEMBL1089635

SCHEMBL1089635

O=S(=O)(c1ccc2ccccc2c1)N1CCCC(N2CCC(Nc3nccc(N4CCCCCC4)n3)C2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.49
MCOLN3 Q8TDD5 2/20 0.45
TSHR P16473 2/20 0.45
EIF2AK3 Q9NZJ5 1/20 0.44
AKR1C3 P42330 4/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPK10 P53779 6/20 0.41
HRH4 Q9H3N8 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
MAPK8 P45983 3/20 0.40
MAPK9 P45984 3/20 0.40
MAP2K4 P45985 1/20 0.40
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
MAP2K6 P52564 1/20 0.40
MAPK11 Q15759 1/20 0.40
MAPK14 Q16539 1/20 0.40
MOK Q9UQ07 1/20 0.40
LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090458 0.97 CXCR4 (0.47) CXCR4MCOLN3TSHREIF2AK3AKR1C3
SCHEMBL1089953 0.96 CXCR4 (0.46) CXCR4MCOLN3TSHREIF2AK3AKR1C3
SCHEMBL1089945 0.92 CXCR4 (0.50) CXCR4MCOLN3TSHRAKR1C3MEN1
SCHEMBL1089328 0.91 CXCR4 (0.55) CXCR4MEN1KMT2AHRH4MAPK8
SCHEMBL1090671 0.89 KDM4E (0.48) CXCR4MCOLN3TSHREIF2AK3AKR1C3
SCHEMBL1090317 0.88 CXCR4 (0.46) CXCR4HRH4RXFP1MAPK8MAPK9
SCHEMBL1091119 0.88 KDM4E (0.48) CXCR4MCOLN3TSHRMEN1KMT2A
SCHEMBL1089055 0.87 CXCR4 (0.47) CXCR4HRH4MAPK8ALDH1A1USP2
SCHEMBL1089353 0.87 CXCR4 (0.52) CXCR4MEN1KMT2AHRH4MAPK8
SCHEMBL1090409 0.87 TSHR (0.45) CXCR4TSHRHRH4ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885MCOLN3 4520/4885TSHR 3693/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CXCR4 1/4885MCOLN3 4520/4885TSHR 3693/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885MCOLN3 4520/4885TSHR 3693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.